Evonik, one of the world’s leading specialty chemicals companies, is building a new plant to produce ultra-high purity colloidal silica at its site in Weston, Michigan, USA which is expected to generate a total capital spending of $7.9 million in 2023 and 2024. ... MORE
Evonik is significantly expanding its commitment to developing solutions for the circular economy. From 2030, the company aims to generate at least €1 billion in additional sales a year from circular products and technologies. ... MORE
Evonik increased the adjusted EBITDA by 8 percent to €485 million in the third quarter 2023 versus the second quarter, also thanks to strict cost discipline. ... MORE
Evonik’s site in Mobile, Alabama, has been awarded the ISCC PLUS sustainability certificate for its use of renewable acetone in the production of isophorone-based products. ... MORE
Dow and Evonik are proud to announce the successful start-up and operation of a pioneering hydrogen peroxide to propylene glycol (HPPG) pilot plant at Evonik’s site in Hanau, Germany. ... MORE
Evonik’s non-animal-derived squalene PhytoSquene® is now available produced under GMP. PhytoSquene® is the first GMP amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. ... MORE
